scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M110598200 |
P698 | PubMed publication ID | 12118000 |
P50 | author | Bart Staels | Q28360345 |
Christophe Blanquart | Q40239377 | ||
P2093 | author name string | Olivier Barbier | |
Jean-Charles Fruchart | |||
Corine Glineur | |||
P2860 | cites work | Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators | Q24652367 |
Progesterone regulation of the progesterone receptor in rat gonadotropes | Q28581455 | ||
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain | Q29614381 | ||
Real time quantitative PCR | Q29616373 | ||
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis | Q33702414 | ||
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
Peroxisome proliferator-activated receptors in inflammation control | Q34262753 | ||
Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors | Q35192645 | ||
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor | Q35752132 | ||
Proteasome-dependent degradation of the human estrogen receptor | Q37160826 | ||
Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells | Q40803637 | ||
The acute phase response is associated with retinoid X receptor repression in rodent liver | Q41728097 | ||
Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation | Q42803719 | ||
Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene | Q42819880 | ||
Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis | Q43608759 | ||
Stabilization of peroxisome proliferator-activated receptor alpha by the ligand | Q43762158 | ||
A novel method for real time quantitative RT-PCR. | Q46544663 | ||
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators | Q47877643 | ||
Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm | Q57244387 | ||
P433 | issue | 40 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ubiquitin-proteasome system | Q47175589 |
P304 | page(s) | 37254-37259 | |
P577 | publication date | 2002-07-12 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes | |
P478 | volume | 277 |
Q53684513 | An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors. |
Q34685423 | Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet |
Q35803035 | Back to your heart: ubiquitin proteasome system-regulated signal transduction |
Q40166312 | Block of nuclear receptor ubiquitination. A mechanism of ligand-dependent control of peroxisome proliferator-activated receptor delta activity |
Q42011450 | CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. |
Q34718191 | Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization |
Q36659845 | Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system |
Q34209733 | Copper modulates the degradation of copper chaperone for Cu,Zn superoxide dismutase by the 26 S proteosome. |
Q44705306 | Dietary regulation of fat oxidative gene expression in different skeletal muscle fiber types |
Q44532471 | Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep |
Q40084685 | Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta |
Q50293438 | Expression of FATP1 (SLC27A1) |
Q28179104 | FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity |
Q33825397 | Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition |
Q34135578 | Genomics of liver transplant injury and regeneration |
Q48249284 | Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation via the coordinated actions of PAQR3 and HUWE1. |
Q36334661 | Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation? |
Q40493369 | Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor |
Q33642453 | Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. |
Q33717532 | Methylation and gene expression responses to ethanol feeding and betaine supplementation in the cystathionine beta synthase-deficient mouse |
Q37791438 | Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation |
Q39471490 | Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia |
Q37190455 | Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis |
Q33941203 | OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62 |
Q37360041 | PPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal. |
Q41763780 | PPARs and lipid ligands in inflammation and metabolism |
Q64096035 | PPARα-Mediated Positive-Feedback Loop Contributes to Cold Exposure Memory |
Q39017204 | PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells |
Q34488895 | Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice |
Q34642573 | Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons |
Q21245560 | Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling |
Q35173859 | Peroxisome proliferator-activated receptors and the cardiovascular system |
Q35207758 | Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation |
Q28263821 | Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins |
Q36232396 | Pleiotropic effects of fibrates |
Q36267294 | Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors |
Q42014305 | Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD |
Q34521305 | Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α. |
Q29347007 | Regulation of peroxisome proliferator-activated receptor-alpha by MDM2. |
Q42183885 | Regulation of peroxisome proliferator-activated receptors by e6-associated protein |
Q24324236 | SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR |
Q33564204 | Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation |
Q92709736 | Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors |
Q47793450 | Sequestration of thermogenic transcription factors in the cytoplasm during development of brown adipose tissue |
Q24541529 | Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis |
Q53792412 | The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity. |
Q34995169 | The G32E functional variant reduces activity of PPARD by nuclear export and post-translational modification in pigs |
Q64073403 | The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα |
Q40524290 | The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c |
Q35964903 | The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. |
Q45064169 | The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes |
Q35911960 | The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination |
Q34483693 | Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity |
Q39125264 | Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis. |
Q36437294 | Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1. |
Q28568693 | ω-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination |
Search more.